Aerie Pharmaceuticals
Signal active
Organization
Contact Information
Overview
Aerie Pharmaceuticals is a biotechnology company that engages in the discovery, development, and commercialization of pharmaceutical products for the treatment of ophthalmic diseases.
The company was founded in 2005 and is headquartered in Bridgewater, New Jersey with research facilities in Research Triangle Park, North Carolina.
Aerie Pharmaceuticals, Inc. is a former subsidiary of Duke University Medical Center.
About
Industries
Biotechnology, Health Care, Pharmaceutical, Medical
Founded
2005
Employees
251-500
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Aerie Pharmaceuticals headquartered in United States, North America, operates in the Biotechnology, Health Care, Pharmaceutical, Medical sector. The company focuses on Biotechnology and has secured $180.6B in funding across 176 round(s). With a team of 251-500 employees, Aerie Pharmaceuticals is actively contributing to advancements in Biotechnology. Their latest funding round, Series B - Aerie Pharmaceuticals, raised $41.4M. Discover more about their projects, partnerships, and impact on our platform.
Employees
Gerald D. Cagle
COO, Cognoptix Inc.; Former SVP, Research & Development; CSO, Alcon Laboratories Inc.
Janet L. Conway
Pharmaceutical Industry Consultant Former Director, Licensing and Development, Pfizer Inc.
Funding Rounds
Funding rounds
11
Investors
5
Lead Investors
0
Total Funding Amount
$1026.1M
Details
2
Aerie Pharmaceuticals has raised a total of $1026.1M in funding over 2 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2005 | Early Stage Venture | 10.0M | ||
| 2011 | Early Stage Venture | 41.4M |
Investors
Aerie Pharmaceuticals is funded by 8 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Deerfield | - | FUNDING ROUND - Deerfield | 200.0M |
| Geoffrey Duyk | - | FUNDING ROUND - Geoffrey Duyk | 10.0M |
| Aerie Pharmaceuticals | - | FUNDING ROUND - Aerie Pharmaceuticals | 10.0M |
| TPG Biotech | - | FUNDING ROUND - TPG Biotech | 10.0M |
Recent Activity
There is no recent news or activity for this profile.